Avapro and Coq drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Avapro (irbesartan) and Coq (coenzyme q - 10). Common drug interactions include abscess among females and flushing among males.

The phase IV clinical study analyzes what interactions people have when they take Avapro and Coq. It is created by eHealthMe based on reports of 63 people who take the same drugs from the FDA, and is updated regularly.

What is Avapro?

Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.

What is Coq?

Coq has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 11,465 Coq users. Check the latest studies of Coq.

On Jul, 11, 2026

63 people who take Avapro and Coq together, and have interactions are studied.

What are the common drug interactions of Avapro and Coq, by gender? *:

female:

Abscess (pus)
Activities of daily living impaired
Alopecia (absence of hair from areas of the body)
Anuria (failure of the kidneys to produce urine)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Bladder disorder
Body height decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Burning sensation
Cerebral haemorrhage (bleeding within the brain)

male:

Flushing (the warm, red condition of human skin)
Drug ineffective
Death
Erythema (redness of the skin)
Feeling hot
Ketosis (a state of elevated levels of ketone bodies in the body)
Myalgia (muscle pain)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Hyperaesthesia
Impaired healing

What are the common drug interactions of Avapro and Coq, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Muscle spasms (muscle contraction)
Vitamin d deficiency
Chest discomfort
Gait disturbance
Antinuclear antibody increased
Bacterial infection
C-reactive protein increased
Eye injury
Flushing (the warm, red condition of human skin)
Fungal infection

50-59:

Malaise (a feeling of general discomfort or uneasiness)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Thrombotic thrombocytopenic purpura (a rare blood disorder characterized by clotting in small blood vessels of the body)
Urinary tract infection
Hyperaesthesia
Impaired healing
Limb injury
Osteomyelitis (infection of bone)
Weight decreased
Abnormal behaviour

60+:

Drug ineffective
Chills (felling of cold)
Feeling hot
Headache (pain in head)
Ketosis (a state of elevated levels of ketone bodies in the body)
Loss of consciousness
Pain in extremity
Pruritus (severe itching of the skin)
Rash
Urine output decreased

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 6 people, 9.52%
Gait Disturbance: 6 people, 9.52%
Type 2 Diabetes: 5 people, 7.94%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 6.35%
Muscle Spasms (muscle contraction): 4 people, 6.35%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 4 people, 6.35%

* Approximation only. Some reports may have incomplete information.

Do you take Avapro and Coq?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously